Showing posts with label Bayer. Show all posts
Showing posts with label Bayer. Show all posts

Monday 22 December 2014

Indian Court Upholds Breaking Of Bayer Patent

 

 

Indian Court Upholds Breaking Of Bayer Patent

Intellectual Property: Supreme Court decision is likely to increase Western pressure on India to tighten patent laws

The Supreme Court of India has dismissed Bayer’s appeal of a decision by the Indian patent office authorizing forced licensing of the cancer drug Nexavar. The ruling will likely increase Western pressure on India to tighten its patent rules.
In 2012, India’s controller general for patents issued a compulsory license of Nexavar, a liver and kidney cancer treatment known generically as sorafenib tosylate. The license allows the Indian drugmaker Natco Pharma to sell generic Nexavar in India after paying a 6% sales royalty to Bayer. The firm’s price for the drug is about $175 a month, 3% of Bayer’s price.
see